Review Article
Induced Pluripotent Stem Cells to Model and Treat Neurogenetic Disorders
Table 1
Genetic neurodevelopmental disorders modeled with iPSCs.
| Disease | Genetic defects | iPSC derived cell types | Disease phenocopied in iPSCs or differentiated cells | Drug or functional tests |
| Rett syndrome | Mutation in MECP2 | Neurons; glutamatergic neurons | Yes | Yes | Mutation in CDKL5 | Neurons | NA | No | Fragile X syndrome | CGG triplet repeat expansion resulting in the silencing of FMR1 | Neurons and glia | Yes | No | Down syndrome | Trisomy 21 | Cortical neurons | Yes | Yes | Angelman syndrome | Lack of UBE3A expression due to genomic imprinting | Neurons | Yes | Yes | Prader-Willi syndrome | Lack of expression of genes in paternal chromosome region 15q11-q13 due to genomic imprinting | Tissues of the three germ layers, including neurons | NA | No | Timothy syndrome | Mutation in the L-type calcium channel 1.2 | Neurons | Yes | Yes |
|
|